- $94.47m
- $159.76m
- $20.13m
- 48
- 82
- 95
- 88
Annual income statement for Phenixfin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46.3 | 21.5 | 32.3 | 15.5 | 20.1 |
Cost of Revenue | |||||
Gross Profit | 11.1 | 0.228 | 25.4 | 10.4 | 14.6 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.2 | 26.7 | 13.9 | 12.4 | 13.6 |
Operating Profit | -22.9 | -5.2 | 18.4 | 3.14 | 6.51 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -96.6 | -65.8 | 1.28 | -6.11 | 26.9 |
Net Income After Taxes | -96.6 | -65.8 | 1.28 | -6.11 | 26.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -96.6 | -65.8 | 1.28 | -6.11 | 26.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -96.6 | -65.8 | 1.28 | -6.11 | 26.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -34.7 | -23.3 | 0.523 | -2.5 | 12.9 |
Dividends per Share | |||||
Special Dividends per Share |